ANTHEM.BSE
ANTHEM · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for ANTHEM.BSE quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Analysts/Institutional Investor Meet/Con. Call Updates
16 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 Jul 2026
Disclosure under SEBI Takeover Regulations
08 Jul 2026
Updates
08 Jul 2026
Credit Rating
03 Jul 2026
Reply to Clarification- Financial results
03 Jul 2026
Copy of Newspaper Publication
01 Jul 2026
Updates
01 Jul 2026
Shareholders meeting
01 Jul 2026
Copy of Newspaper Publication
29 Jun 2026
Trading Window
26 Jun 2026
Disclosure under SEBI Takeover Regulations
23 Jun 2026
Disclosure under SEBI Takeover Regulations
23 Jun 2026
Disclosure under SEBI Takeover Regulations
23 Jun 2026
Clarification - Financial Results
17 Jun 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Dividend - Rs 2 Per Share
Dividend - Rs 2 Per Share
Ex-date: 25 Jun 2026
Board Meetings
21 Jul 2026
To consider and approve the financial results for the period ended Jun 30, 2026
21 Jul 2026
Anthem Biosciences Limited has informed the Exchange about Board Meeting to be held on 21-Jul-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2026 .
19 May 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
19 May 2026
Anthem Biosciences Limited has informed the Exchange about Board Meeting to be held on 19-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
05 Feb 2026
Anthem Biosciences Limited has informed the Exchange about Board Meeting to be held on 05-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
05 Feb 2026
To consider and approve the financial results for the period ended December 31, 2025
08 Nov 2025
Anthem Biosciences Limited has informed the Exchange about Board Meeting to be held on 08-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 .
08 Nov 2025
To consider and approve the financial results for the period ended September 30, 2025